Part I. Introduction to High Content Screening Past, Present, and Future of High Content Screening and the Field of Cellomics D. Lansing Taylor A Pharmaceutical Company User’s Perspective on the Potential of High Content Screening in Drug Discovery Ann F. Hoffman and Ralph J. Garippa Linking Microscopy and High Content Screening in Large-Scale Biomedical Research James G. Evans and Paul Matsudaira. Part II. Instrumentation, Biological Application Software, and Sample Preparation Requirements, Features, and Performance of High Content Screening Platforms Albert H. Gough and Paul A. Johnston Characteristics and Value of Directed Algorithms in High Content Screening Richik N. Ghosh, Oleg Lapets, and Jeffrey R. Haskins Characteristics and Value of Machine Learning for Imaging in High Content Screening Juergen A. Klenk Tools for Quantitative and Validated Measurements of Cells Anne L. Plant, John T. Elliott, Alessandro Tona, Dennis McDaniel, and Kurt J. Langenbach Automated Cell Plating and Sample Treatments for Fixed Cells in High Content Assays Gillian R. Richards, Julie E. Kerby, Grace K. Y. Chan, and Peter B. Simpson Differentiating Primary Human Cells in Rapid-Throughput Discovery Applications Daniel R. Marshak and Dale E. Greenwalt Use of the CellCard™ System for Analyzing Multiple Cell Types in Parallel Oren Beske, Daniel Bassoni, and Simon Goldbard Part III. Reagents Reagents to Measure and Manipulate Cell Functions Kenneth A. Giuliano, D. Lansing Taylor, and Alan S. Waggoner Fluorescent Proteins and Engineered Cell Lines Nick Thomas Optimizing the Integration of Immunoreagents and Fluorescent Probes for Multiplexed High Content Screening Assays Kenneth A. Giuliano The HaloTag™: A Novel Technology for Cell Imaging andProtein Analysis Georgyi V. Los and Keith Wood Protein Labeling With FlAsH and ReAsH Thomas Machleidt, Matt Robers, and George T. Hanson Exploiting Network Biology to Improve Drug Discovery Marnie L. MacDonald and John K. Westwick Physiological Indicators of Cell Function Michael J. Ignatius and Jeffrey T. Hung The Use of siRNA to Validate Immunofluorescence Studies K. Gregory Moore, Wayne Speckmann, and Ronald P. Herzig Caged Substrates Applied to High Content Screening: An Introduction With an Eye to the Future Peter G. Conrad, II, Rajesh V. Chavli, and Richard S. Givens Part IV. Informatics and Bioinformatics Overview of Informatics for High Content Screening R. Terry Dunlay, Wallace J. Czekalski, and Mark A. Collins Large-Scale Data Management for High Content Screening Leon S. Garfinkel An Integrated Biomedical Knowledge Extraction and Analysis Platform: Using Federated Search and Document Clustering Technology Donald P. Taylor Visualization of High Content Screening Data Matthew J. Anstett Pathway Mapping Tools for Analysis of High Content Data Sean Ekins, Yuri Nikolsky, Andrej Bugrim, Eugene Kirillov, and Tatiana Nikolskaya Part V. Assays and Applications of High Content Screening Systems Biology in Cancer Research: Genomics to Cellomics Jackie L. Stilwell, Yinghui Guan, Richard M. Neve, and Joe W. Gray Target Validation in Drug Discovery Robert A. Blake High Content Screening as a Screening Tool in Drug Discovery Anthony Nichols Discovery of Protein Kinase Phosphatase Inhibitors Andreas Vogt and John S. Lazo High Content Translocation Assays for Pathway Profiling Frosty Loechel, Sara Bjørn, Viggo Linde, Morten Præstegaard, and Len Pagliaro In Vitro Cytotoxicity Assessment Peter
"Sinopsis" puede pertenecer a otra edición de este libro.
High content screening (HCS) was developed by Cellomics Inc. in the mid-1990s to address the need for a platform that could be used in the discovery-driven research and development required to understand the functions of genes and gene products at the level of the cell. High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery discusses its use as a high throughput platform to understand the functions of genes, RNA, proteins, and other cellular constituents at the level of the living cell.
High Content Screening is assembled to assist both existing users of HCS, as well as investigators considering the addition of a discovery-driven platform to their research and development activities. The chapters have been organized into sections that highlight the importance of integrating instrumentation, application software, reagents, and informatics. In addition, there is a combination of pure review chapters on key topics and specific methods chapters.
"Sobre este título" puede pertenecer a otra edición de este libro.
Librería: Brook Bookstore On Demand, Napoli, NA, Italia
Condición: new. Questo è un articolo print on demand. Nº de ref. del artículo: MUALW3SQYY
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPrices, Columbia, MD, Estados Unidos de America
Condición: New. Nº de ref. del artículo: 14384721-n
Cantidad disponible: 15 disponibles
Librería: Ria Christie Collections, Uxbridge, Reino Unido
Condición: New. In. Nº de ref. del artículo: ria9781617377464_new
Cantidad disponible: Más de 20 disponibles
Librería: GreatBookPricesUK, Woodford Green, Reino Unido
Condición: New. Nº de ref. del artículo: 14384721-n
Cantidad disponible: Más de 20 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -There has always been some tension between proponents of hypothesis-driven and discovery-driven research in the broad field of life sciences. Academic research has been primarily focused on hypothesis-driven research. However, the success of the human genome project, a discovery-driven research approach, has opened the door to adding other types of discovery-driven research to a continuum of research approaches. In contrast, drug discovery research in the pharmaceutical industry has embraced discovery-driven research for many years. A good example has been the discovery of active compounds from large chemical libraries, through screening campaigns. The success of the human genome project has also demonstrated the need for both academic researchers and industrial researchers to now understand the functions of genes and gene products. The cell is the basic unit of life and it has been at the cellular level where function can be demonstrated most cost-effectively and rapidly. High content screening (HCS) was developed by Cellomics Inc. in the mid-1990s to address the need for a platform that could be used in the discovery-driven research and development required to understand the functions of genes and gene products at the level of the cell. 464 pp. Englisch. Nº de ref. del artículo: 9781617377464
Cantidad disponible: 2 disponibles
Librería: moluna, Greven, Alemania
Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Part I. Introduction to High Content Screening Past, Present, and Future of High Content Screening and the Field of Cellomics D. Lansing Taylor A Pharmaceutical Company User s Perspective on the Potential of High Content Screening in Drug Discovery Ann F. Nº de ref. del artículo: 458521603
Cantidad disponible: Más de 20 disponibles
Librería: THE SAINT BOOKSTORE, Southport, Reino Unido
Paperback / softback. Condición: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Nº de ref. del artículo: C9781617377464
Cantidad disponible: Más de 20 disponibles
Librería: Books Puddle, New York, NY, Estados Unidos de America
Condición: New. pp. 462. Nº de ref. del artículo: 262571979
Cantidad disponible: 4 disponibles
Librería: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condición: New. Editor(s): Taylor, D.L. Series: Methods in Molecular Biology. Num Pages: 462 pages, 168 black & white illustrations, biography. BIC Classification: MF. Category: (P) Professional & Vocational. Dimension: 254 x 178 x 23. Weight in Grams: 796. . 2010. Softcover reprint of hardcover 1st ed. 2006. paperback. . . . . Nº de ref. del artículo: V9781617377464
Cantidad disponible: 15 disponibles
Librería: preigu, Osnabrück, Alemania
Taschenbuch. Condición: Neu. High Content Screening | D Lansing Taylor | Taschenbuch | 464 S. | Englisch | 2010 | Humana Press | EAN 9781617377464 | Verantwortliche Person für die EU: Humana Press in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. Nº de ref. del artículo: 107146359
Cantidad disponible: 5 disponibles